Our results suggest that acquired resistance to leptin and insulin, rather than high levels of these hormones in the circulation, may have a causal role underlying the epidemiological correlation between obesity and cancer risk. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.